Related Experiment Video
Updated: Jun 22, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma
Suhu Liu1, Paul Howell, Suping Ren
1Dana-Farber Cancer Institute, Boston, MA 02115, USA. suhu_liu@dfci.harvard.edu
Abstract:
The exact cellular and molecular mechanisms involved in melanoma tumorigenesis remain obscure. Previous gene expression profiling analyses performed upon NHEM and human melanoma samples identified WFDC1 as one of the most frequently down-regulated genes. Here we further showed that NHEM readily express WFDC1 but expression is reduced or completely lost in 80% of the patients-derived melanoma cell lines and tissue samples examined. Furthermore, we show that promoter hypermethylation accounts for the silencing of the WFDC1 gene in 20% of the melanoma cell lines examined. The over-expression of WFDC1 in two metastatic melanoma cell lines, A375 and LOX, resulted in a significant delay of tumor growth in a murine xenograft model, despite a non-significant difference in tumor cell growth in vitro. Gene expression microarray analysis and further expression validation suggests that the Dickkopf-1 (Dkk1) gene is up-regulated in WFDC1 over-expressing cell lines, suggesting that the tumor suppressive function of WFDC1 may be partially a result of up-regulated Dkk1 gene expression, which is known to be a potent inhibitor of the Wnt signaling pathway.
Insights
WFDC1 gene expression is reduced in melanoma. Overexpressing WFDC1 suppressed tumor growth in mice, potentially by increasing Dickkopf-1 (Dkk1) and inhibiting Wnt signaling.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Melanoma tumorigenesis mechanisms are not fully understood.
- WFDC1 is frequently down-regulated in melanoma.
- WFDC1 expression is lost in 80% of melanoma samples.
Purpose of the Study:
- To investigate the role of WFDC1 in melanoma.
- To elucidate the mechanisms of WFDC1 down-regulation.
- To evaluate the therapeutic potential of WFDC1.
Main Methods:
- Gene expression profiling of normal human epidermal melanocytes (NHEM) and melanoma samples.
- Analysis of WFDC1 promoter methylation.
- Overexpression of WFDC1 in melanoma cell lines (A375, LOX) and assessment in a murine xenograft model.
- Gene expression microarray analysis to identify downstream targets.
Main Results:
- WFDC1 expression is significantly reduced or lost in most melanoma cell lines and tissues.
- Promoter hypermethylation causes WFDC1 silencing in 20% of melanoma cell lines.
- WFDC1 overexpression delayed tumor growth in vivo, but not in vitro.
- WFDC1 overexpression led to increased Dickkopf-1 (Dkk1) gene expression.
Conclusions:
- WFDC1 acts as a tumor suppressor in melanoma.
- WFDC1 silencing via promoter hypermethylation is a mechanism in melanoma.
- WFDC1's tumor suppressive function may involve up-regulation of Dkk1, inhibiting Wnt signaling.
Related Concept Videos
Canonical Wnt Signaling Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
MAPK Signaling Cascades
Pleiotropy
Non-Canonical Wnt Signaling Pathways

